⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7380102 | 0.81 | — | — | |
| SCHEMBL10947172 | 0.77 | — | — | |
| SCHEMBL16670518 | 0.75 | — | — | |
| SCHEMBL266174 | 0.75 | — | — | |
| SCHEMBL6999271 | 0.75 | — | — | |
| SCHEMBL31612604 | 0.74 | ADRA1D (0.37) | — | |
| SCHEMBL25239748 | 0.73 | ADRA1D (0.36) | — | |
| SCHEMBL7961734 | 0.73 | ADAMTS5 (0.40) | — | |
| SCHEMBL11725099 | 0.73 | ADRA1D (0.39) | — | |
| SCHEMBL20678310 | 0.72 | ADRA1D (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097104-A1 | THIENYL COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER | PGI DRUG DISCOVERY LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025049326-A1 | TRICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | BIOCRYST PHARMACEUTICALS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11667630-B2 | Nitrogen-containing 6-membered cyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| US-11667630-B2 | Nitrogen-containing 6-membered cyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| US-11667630-B2 | Nitrogen-containing 6-membered cyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| CN-111511736-B | Nitrogen-containing 6-membered ring compound | 旭化成制药株式会社 | 2023-03-24 | — | — | CN | disclosed |
| EP-3733665-B1 | 2-OXO-1,3,4-THIADIAZINAN-3-YL MOIETY CONTAINING COMPOUNDS WITH EP4 RECEPTOR AGONIST ACTIVITY | ASAHI KASEI PHARMA CORP (JP) | 2022-09-28 | — | — | EP | disclosed |
| WO-2000015634-A2 | HIV PROTEASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-03-23 | — | — | WO | disclosed |
| US-6040328-A | ANTIOXIDANT AGENTS HAVING CYTOPROTECTING ACTIVITY, AND WATER SOLUBLE | OXIS INTERNATIONAL S.A. (US) | 2000-03-21 | — | — | US | disclosed |
| US-5973009-A | ANTIOXIDANT AND CYTOPROTECTING ACTIVITY | OXIS INTERNATIONAL S.A. (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0948500-A1 | CYCLIC ORGANOSELENIUM COMPOUNDS, THEIR PREPARATION AND THEIR USES | OXIS Isle of Man, Limited (GB) | 1999-10-13 | — | — | EP | disclosed |
| WO-1999006410-A1 | HYDROXAMIC ACID SUBSTITUTED FUSED HETEROCYCLIC METALLOPROTEINASE INHIBITORS | AMGEN INC. (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1998029417-A1 | CYCLIC ORGANOSELENIUM COMPOUNDS, THEIR PREPARATION AND THEIR USES | OXIS ISLE OF MAN, LIMITED (GB) | 1998-07-09 | — | — | WO | disclosed |
| EP-0850924-A1 | Aromatic diselenides and selenosulphides for use as antioxidant agents | OXIS Isle of Man, Limited (GB) | 1998-07-01 | — | — | EP | disclosed |
| EP-0413293-A2 | 1-(Benzo[b]thienyl)-2-(thienyl) ethenes and related compounds, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-02-20 | — | — | EP | disclosed |
| US-4904674-A | FREE OF AGGLOMERATION OF FIBRILLATION | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1990-02-27 | — | — | US | disclosed |
| US-4560701-A | ANTIINFLAMMATORY, ANALGESIC AGENTS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1985-12-24 | — | — | US | disclosed |